Rezo Therapeutics
Rezo Therapeutics uses AI-driven network biology to find new drug targets and therapies in plain terms: it maps disease networks to reveal actionable intervention points. The company combines artificial intelligence with unbiased experimental technologies in a proprietary, fully integrated discovery platform that supports target identification and therapeutic hypothesis generation. Rezo operates as a B2B SaaS-like discovery platform serving biopharmaceutical partners, initially focusing on oncology while remaining disease-agnostic. The platform is positioned for collaborations and partnerships with drug developers and academic groups to advance candidate discovery and development.
Rezo Therapeutics
Rezo Therapeutics uses AI-driven network biology to find new drug targets and therapies in plain terms: it maps disease networks to reveal actionable intervention points. The company combines artificial intelligence with unbiased experimental technologies in a proprietary, fully integrated discovery platform that supports target identification and therapeutic hypothesis generation. Rezo operates as a B2B SaaS-like discovery platform serving biopharmaceutical partners, initially focusing on oncology while remaining disease-agnostic. The platform is positioned for collaborations and partnerships with drug developers and academic groups to advance candidate discovery and development.